SIMILAR PATTERNS OF AMINO ACIDS FOR 2BXQ_A_P1ZA2002
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1cbk | PROTEIN(7,8-DIHYDRO-6-HYDROXYMETHYLPTERIN-PYROPHOSPHOKINASE) (Haemophilusinfluenzae) |
PF01288(HPPK) | 6 | LEU A 94LEU A 19LEU A 23ILE A 26ILE A 6ALA A 7 | None | 1.05A | 2bxqA-1cbkA:undetectable | 2bxqA-1cbkA:17.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1e6v | METHYL-COENZYME MREDUCTASE I BETASUBUNIT (Methanopyruskandleri) |
PF02241(MCR_beta)PF02783(MCR_beta_N) | 5 | LEU B 113LEU B 51ILE B 54ILE B 143ALA B 142 | None | 0.99A | 2bxqA-1e6vB:1.0 | 2bxqA-1e6vB:21.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1g8x | MYOSIN II HEAVYCHAIN FUSED TOALPHA-ACTININ 3 (Dictyosteliumdiscoideum) |
PF00063(Myosin_head)PF00435(Spectrin)PF02736(Myosin_N) | 5 | LEU A 307LEU A 285ILE A 280ILE A 348ALA A 349 | None | 0.97A | 2bxqA-1g8xA:1.7 | 2bxqA-1g8xA:21.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1jmy | BILE-SALT-ACTIVATEDLIPASE (Homo sapiens) |
PF00135(COesterase) | 5 | LEU A 3LEU A 98ILE A 137ILE A 178ALA A 179 | None | 0.85A | 2bxqA-1jmyA:0.4 | 2bxqA-1jmyA:22.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1jug | LYSOZYME (Tachyglossusaculeatus) |
PF00062(Lys) | 5 | LEU A 12LEU A 92ILE A 88ILE A 55ALA A 32 | None | 0.94A | 2bxqA-1jugA:undetectable | 2bxqA-1jugA:12.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1jx2 | MYOSIN-2 HEAVYCHAIN,DYNAMIN-A (Dictyosteliumdiscoideum) |
PF00063(Myosin_head)PF02736(Myosin_N) | 5 | LEU A 318LEU A 296ILE A 291ILE A 359ALA A 360 | None | 0.98A | 2bxqA-1jx2A:3.2 | 2bxqA-1jx2A:20.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1o5j | PERIPLASMIC DIVALENTCATION TOLERANCEPROTEIN (Thermotogamaritima) |
PF03091(CutA1) | 5 | LEU A 69HIS A 73LEU A 21ILE A 27ALA A 53 | None | 1.02A | 2bxqA-1o5jA:undetectable | 2bxqA-1o5jA:11.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1tf0 | SERUM ALBUMIN (Homo sapiens) |
PF00273(Serum_albumin) | 6 | LEU A 219ARG A 222PHE A 223LEU A 238HIS A 242ILE A 264 | NoneCIT A2001 ( 2.9A)NoneDKA A1003 (-4.3A)DKA A1003 (-3.7A)None | 1.45A | 2bxqA-1tf0A:38.1 | 2bxqA-1tf0A:99.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1tf0 | SERUM ALBUMIN (Homo sapiens) |
PF00273(Serum_albumin) | 10 | LYS A 199LEU A 219ARG A 222PHE A 223LEU A 238HIS A 242ILE A 264SER A 287ILE A 290ALA A 291 | CIT A2001 ( 2.7A)NoneCIT A2001 ( 2.9A)NoneDKA A1003 (-4.3A)DKA A1003 (-3.7A)NoneNoneDKA A1003 ( 4.5A)CIT A2001 ( 3.9A) | 0.82A | 2bxqA-1tf0A:38.1 | 2bxqA-1tf0A:99.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1tf0 | SERUM ALBUMIN (Homo sapiens) |
PF00273(Serum_albumin) | 11 | LYS A 199LEU A 219PHE A 223LEU A 238HIS A 242ARG A 257LEU A 260ILE A 264SER A 287ILE A 290ALA A 291 | CIT A2001 ( 2.7A)NoneNoneDKA A1003 (-4.3A)DKA A1003 (-3.7A)DKA A1003 (-4.1A)NoneNoneNoneDKA A1003 ( 4.5A)CIT A2001 ( 3.9A) | 0.83A | 2bxqA-1tf0A:38.1 | 2bxqA-1tf0A:99.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1uli | BIPHENYL DIOXYGENASESMALL SUBUNIT (Rhodococcusjostii) |
PF00866(Ring_hydroxyl_B) | 5 | PHE B 46LEU B 37HIS B 111ILE B 95SER B 184 | None | 0.98A | 2bxqA-1uliB:undetectable | 2bxqA-1uliB:14.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1vhf | PERIPLASMIC DIVALENTCATION TOLERANCEPROTEIN (Thermotogamaritima) |
PF03091(CutA1) | 5 | LEU A 69HIS A 73LEU A 21ILE A 27ALA A 53 | None | 0.99A | 2bxqA-1vhfA:undetectable | 2bxqA-1vhfA:11.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1vl4 | PMBA-RELATED PROTEIN (Thermotogamaritima) |
PF01523(PmbA_TldD) | 5 | LEU A 235LEU A 403LEU A 430ILE A 396ILE A 356 | None | 0.90A | 2bxqA-1vl4A:undetectable | 2bxqA-1vl4A:21.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1w36 | EXODEOXYRIBONUCLEASEV GAMMA CHAIN (Escherichiacoli) |
PF04257(Exonuc_V_gamma) | 5 | LEU C 224LEU C 314ILE C 213ILE C 216ALA C 218 | None | 1.02A | 2bxqA-1w36C:0.0 | 2bxqA-1w36C:19.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1w55 | ISPD/ISPFBIFUNCTIONAL ENZYME (Campylobacterjejuni) |
PF01128(IspD)PF02542(YgbB) | 5 | LEU A 286LEU A 300ILE A 303ILE A 336ALA A 326 | None | 0.90A | 2bxqA-1w55A:undetectable | 2bxqA-1w55A:20.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2a9j | BISPHOSPHOGLYCERATEMUTASE (Homo sapiens) |
PF00300(His_Phos_1) | 5 | LEU A 199LEU A 195ILE A 185ILE A 173ALA A 174 | None | 0.99A | 2bxqA-2a9jA:undetectable | 2bxqA-2a9jA:18.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2dg0 | DRP35 (Staphylococcusaureus) |
PF08450(SGL) | 5 | ARG A 80LEU A 47LEU A 309ILE A 71ILE A 78 | None | 1.00A | 2bxqA-2dg0A:undetectable | 2bxqA-2dg0A:20.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2dh3 | 4F2 CELL-SURFACEANTIGEN HEAVY CHAIN (Homo sapiens) |
PF00128(Alpha-amylase) | 5 | LEU A 192PHE A 189LEU A 143LEU A 129ILE A 163 | None | 0.87A | 2bxqA-2dh3A:undetectable | 2bxqA-2dh3A:22.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2fno | AGR_PAT_752P (Agrobacteriumfabrum) |
no annotation | 6 | LEU A 172LEU A 112LEU A 133ILE A 137ILE A 187ALA A 177 | NoneNoneNoneNoneSCN A 237 ( 3.9A)SCN A 237 (-3.4A) | 1.34A | 2bxqA-2fnoA:undetectable | 2bxqA-2fnoA:16.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2g29 | NITRATE TRANSPORTPROTEIN NRTA (Synechocystissp.) |
PF13379(NMT1_2) | 5 | LEU A 175LEU A 204ILE A 200ILE A 157ALA A 256 | None | 1.02A | 2bxqA-2g29A:undetectable | 2bxqA-2g29A:21.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2g5x | RIBOSOME-INACTIVATING PROTEIN (Silenechalcedonica) |
PF00161(RIP) | 5 | LEU A 135PHE A 190ILE A 196ILE A 177ALA A 171 | None | 1.03A | 2bxqA-2g5xA:undetectable | 2bxqA-2g5xA:17.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2i5p | GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE1 (Kluyveromycesmarxianus) |
PF00044(Gp_dh_N)PF02800(Gp_dh_C) | 5 | LEU O 16ILE O 25SER O 2ILE O 3ALA O 4 | None | 1.02A | 2bxqA-2i5pO:undetectable | 2bxqA-2i5pO:19.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2j04 | YDR362CP (Saccharomycescerevisiae) |
no annotation | 6 | LEU B 276ARG B 281PHE B 273LEU B 256ILE B 285ILE B 616 | None | 1.48A | 2bxqA-2j04B:undetectable | 2bxqA-2j04B:22.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2oze | ORF DELTA' (Streptococcuspyogenes) |
PF13614(AAA_31) | 5 | LEU A 125LEU A 100LEU A 105ILE A 119ILE A 71 | None | 0.99A | 2bxqA-2ozeA:undetectable | 2bxqA-2ozeA:19.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2qh5 | MANNOSE-6-PHOSPHATEISOMERASE (Helicobacterpylori) |
PF00483(NTP_transferase) | 5 | PHE A 191HIS A 112LEU A 8ILE A 92ILE A 244 | None | 0.99A | 2bxqA-2qh5A:undetectable | 2bxqA-2qh5A:20.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2rfo | NUCLEOPORIN NIC96 (Saccharomycescerevisiae) |
PF04097(Nic96) | 5 | LEU A 513LEU A 260ILE A 234ILE A 508ALA A 507 | None | 1.02A | 2bxqA-2rfoA:undetectable | 2bxqA-2rfoA:22.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2vha | PERIPLASMIC BINDINGTRANSPORT PROTEIN (Shigellaflexneri) |
PF00497(SBP_bac_3) | 6 | LEU A 10PHE A 222LEU A 58LEU A 63ILE A 19ALA A 53 | None | 1.28A | 2bxqA-2vhaA:undetectable | 2bxqA-2vhaA:17.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2vtw | FIBER PROTEIN 2 (Fowlaviadenovirus A) |
PF16812(AdHead_fibreRBD) | 6 | LEU A 383PHE A 277LEU A 347ILE A 352ILE A 394ALA A 393 | None | 1.25A | 2bxqA-2vtwA:undetectable | 2bxqA-2vtwA:14.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2w61 | GLYCOLIPID-ANCHOREDSURFACE PROTEIN 2 (Saccharomycescerevisiae) |
PF03198(Glyco_hydro_72)PF07983(X8) | 6 | LEU A 133LEU A 131LEU A 168ILE A 209SER A 164ALA A 161 | None | 1.45A | 2bxqA-2w61A:undetectable | 2bxqA-2w61A:22.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xa7 | AP-2 COMPLEX SUBUNITBETA (Homo sapiens) |
PF01602(Adaptin_N) | 5 | LEU B 436LEU B 465ILE B 451ILE B 429ALA B 430 | None | 0.97A | 2bxqA-2xa7B:undetectable | 2bxqA-2xa7B:23.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ywo | PROBABLETHIOL-DISULFIDEISOMERASE/THIOREDOXIN (Thermusthermophilus) |
PF00578(AhpC-TSA) | 5 | LEU A 122LEU A 157ARG A 159LEU A 158ALA A 152 | None | 1.00A | 2bxqA-2ywoA:undetectable | 2bxqA-2ywoA:14.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2z63 | TOLL-LIKE RECEPTOR4, VARIABLELYMPHOCYTE RECEPTORB (Eptatretusburgeri;Homo sapiens) |
PF11921(DUF3439)PF13516(LRR_6)PF13855(LRR_8) | 5 | LEU A 83LEU A 85LEU A 66ILE A 48ALA A 97 | None | 1.01A | 2bxqA-2z63A:undetectable | 2bxqA-2z63A:21.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2z7x | TOLL-LIKE RECEPTOR1, VARIABLELYMPHOCYTE RECEPTORB (Eptatretusburgeri;Homo sapiens) |
PF11921(DUF3439)PF13855(LRR_8) | 6 | LEU B 400LEU B 425LEU B 428ILE B 405ILE B 390ALA B 391 | None | 1.46A | 2bxqA-2z7xB:undetectable | 2bxqA-2z7xB:23.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2zau | SELENIDE, WATERDIKINASE (Aquifexaeolicus) |
PF00586(AIRS)PF02769(AIRS_C) | 6 | LEU A 143PHE A 141LEU A 121LEU A 118ILE A 114ALA A 74 | None | 1.33A | 2bxqA-2zauA:undetectable | 2bxqA-2zauA:19.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3eqq | BENZENE1,2-DIOXYGENASESUBUNIT BETA (Pseudomonasputida) |
PF00866(Ring_hydroxyl_B) | 5 | PHE B 46LEU B 37HIS B 111ILE B 95SER B 184 | None | 1.00A | 2bxqA-3eqqB:undetectable | 2bxqA-3eqqB:13.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3fjv | UNCHARACTERIZEDNOVEL PROTEIN (Burkholderiapseudomallei) |
PF12007(DUF3501) | 5 | LEU A 86LEU A 116ILE A 166ILE A 180ALA A 185 | None | 0.91A | 2bxqA-3fjvA:2.7 | 2bxqA-3fjvA:16.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ivf | TALIN-1 (Mus musculus) |
PF00373(FERM_M)PF02174(IRS)PF09379(FERM_N)PF16511(FERM_f0) | 5 | LEU A 68PHE A 19LEU A 62ILE A 32ILE A 8 | None | 1.02A | 2bxqA-3ivfA:2.3 | 2bxqA-3ivfA:21.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3kez | PUTATIVE SUGARBINDING PROTEIN (Bacteroidesvulgatus) |
PF07980(SusD_RagB)PF14322(SusD-like_3) | 5 | LEU A 117LEU A 48ILE A 51ILE A 143ALA A 142 | None | 0.97A | 2bxqA-3kezA:undetectable | 2bxqA-3kezA:20.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3kl4 | SIGNAL RECOGNITION54 KDA PROTEIN (Sulfolobussolfataricus) |
PF00448(SRP54)PF02881(SRP54_N)PF02978(SRP_SPB) | 5 | PHE A 70LEU A 78LEU A 47ILE A 51ILE A 27 | None | 1.02A | 2bxqA-3kl4A:4.0 | 2bxqA-3kl4A:22.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3kzu | 3-OXOACYL-(ACYL-CARRIER-PROTEIN)SYNTHASE II (Brucellamelitensis) |
PF00109(ketoacyl-synt)PF02801(Ketoacyl-synt_C) | 5 | LEU A 386LEU A 322ILE A 308ILE A 336ALA A 333 | None | 0.99A | 2bxqA-3kzuA:undetectable | 2bxqA-3kzuA:22.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3l2k | EHPF (Pantoeaagglomerans) |
PF00501(AMP-binding) | 5 | LEU A 198LEU A 216LEU A 213ILE A 233ALA A 138 | None | 0.98A | 2bxqA-3l2kA:undetectable | 2bxqA-3l2kA:19.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3lnt | 2,3-BISPHOSPHOGLYCERATE-DEPENDENTPHOSPHOGLYCERATEMUTASE (Burkholderiapseudomallei) |
PF00300(His_Phos_1) | 5 | LEU A 193LEU A 189ILE A 179ILE A 167ALA A 168 | None | 1.04A | 2bxqA-3lntA:undetectable | 2bxqA-3lntA:17.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3niw | HALOACIDDEHALOGENASE-LIKEHYDROLASE (Bacteroidesthetaiotaomicron) |
PF08282(Hydrolase_3) | 5 | LEU A 57LEU A 14ILE A 6ILE A 263ALA A 260 | None | 1.02A | 2bxqA-3niwA:undetectable | 2bxqA-3niwA:17.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3o82 | PEPTIDE ARYLATIONENZYME (Acinetobacterbaumannii) |
PF00501(AMP-binding) | 6 | LEU A 85LEU A 160LEU A 170ILE A 173ILE A 93ALA A 89 | None | 1.47A | 2bxqA-3o82A:undetectable | 2bxqA-3o82A:22.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3oja | ANOPHELESPLASMODIUM-RESPONSIVE LEUCINE-RICHREPEAT PROTEIN 1 (Anophelesgambiae) |
PF13855(LRR_8) | 5 | LEU B 377PHE B 401LEU B 393ILE B 396ILE B 412 | None | 1.03A | 2bxqA-3ojaB:undetectable | 2bxqA-3ojaB:21.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3p8c | NCK-ASSOCIATEDPROTEIN 1 (Homo sapiens) |
PF09735(Nckap1) | 5 | LEU B 999LEU B1043ILE B 910SER B 860ALA B 864 | None | 1.04A | 2bxqA-3p8cB:4.3 | 2bxqA-3p8cB:20.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3qtg | PYRUVATE KINASE (Pyrobaculumaerophilum) |
PF00224(PK)PF02887(PK_C) | 5 | LEU A 218LEU A 187SER A 203ILE A 202ALA A 201 | None | 1.02A | 2bxqA-3qtgA:undetectable | 2bxqA-3qtgA:22.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3t66 | NICKEL ABCTRANSPORTER(NICKEL-BINDINGPROTEIN) (Bacillushalodurans) |
PF00496(SBP_bac_5) | 6 | LEU A 137PHE A 133HIS A 29LEU A 100ILE A 112ILE A 115 | None | 1.49A | 2bxqA-3t66A:undetectable | 2bxqA-3t66A:22.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3vml | 3-ISOPROPYLMALATEDEHYDROGENASE (Shewanellabenthica;Shewanellaoneidensis) |
PF00180(Iso_dh) | 5 | ARG A 107ILE A 132SER A 252ILE A 255ALA A 256 | IPM A 401 (-4.5A)NoneNoneNoneNone | 1.03A | 2bxqA-3vmlA:undetectable | 2bxqA-3vmlA:20.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4akk | NITRATE REGULATORYPROTEIN (Klebsiellaoxytoca) |
PF03861(ANTAR)PF08376(NIT) | 5 | LEU A 86PHE A 82LEU A 97ILE A 142ALA A 102 | None | 0.92A | 2bxqA-4akkA:3.1 | 2bxqA-4akkA:22.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ay1 | CHITINASE-3-LIKEPROTEIN 2 (Homo sapiens) |
PF00704(Glyco_hydro_18) | 6 | LEU A 158PHE A 111LEU A 162LEU A 140ILE A 101ALA A 182 | None | 1.44A | 2bxqA-4ay1A:undetectable | 2bxqA-4ay1A:20.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4bju | N-ACETYLGLUCOSAMINE-PHOSPHATE MUTASE (Aspergillusfumigatus) |
PF00408(PGM_PMM_IV)PF02878(PGM_PMM_I) | 5 | PHE A 389HIS A 441LEU A 434ILE A 421ALA A 416 | None | 0.99A | 2bxqA-4bjuA:undetectable | 2bxqA-4bjuA:21.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4cmh | HEAVY CHAIN OFSAR650984-FABFRAGMENT (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 5 | LYS B 63LEU B 86LEU B 83LEU B 20ALA B 92 | None | 0.97A | 2bxqA-4cmhB:undetectable | 2bxqA-4cmhB:18.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4evf | GIARDIN SUBUNITALPHA-1 (Giardiaintestinalis) |
PF00191(Annexin) | 5 | PHE A 71LEU A 66ILE A 54ILE A 23ALA A 24 | None | 1.02A | 2bxqA-4evfA:undetectable | 2bxqA-4evfA:17.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4f0b | THIOL TRANSFERASE (Phanerochaetechrysosporium) |
PF00043(GST_C)PF02798(GST_N) | 6 | LEU A 29LEU A 91LEU A 88ILE A 181ILE A 24ALA A 23 | None | 1.17A | 2bxqA-4f0bA:undetectable | 2bxqA-4f0bA:15.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4gtn | ANTHRANILATEPHOSPHORIBOSYLTRANSFERASE (Acinetobactersp. ADP1) |
PF00591(Glycos_transf_3)PF02885(Glycos_trans_3N) | 5 | LEU A 285PHE A 111LEU A 251ILE A 316ALA A 313 | None | 0.99A | 2bxqA-4gtnA:undetectable | 2bxqA-4gtnA:19.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4h1g | MALTOSE BINDINGPROTEIN-CAKAR3 MOTORDOMAIN FUSIONPROTEIN (Candidaalbicans;Escherichiacoli) |
PF00225(Kinesin)PF13416(SBP_bac_8) | 5 | HIS A 557LEU A 498ILE A 488ILE A 495ALA A 494 | None | 0.99A | 2bxqA-4h1gA:undetectable | 2bxqA-4h1gA:21.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4inj | LMO1638 PROTEIN (Listeriamonocytogenes) |
PF02016(Peptidase_S66) | 5 | LEU A 211LEU A 208ILE A 201ILE A 305ALA A 117 | None | 0.94A | 2bxqA-4injA:undetectable | 2bxqA-4injA:19.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4jg5 | PUTATIVE CELLADHESION PROTEIN (Parabacteroidesdistasonis) |
PF06321(P_gingi_FimA) | 5 | LEU A 356PHE A 328LEU A 191ILE A 194ILE A 210 | None | 0.84A | 2bxqA-4jg5A:undetectable | 2bxqA-4jg5A:18.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4lhs | UNCHARACTERIZEDPROTEIN (Bacteroidesovatus) |
PF14606(Lipase_GDSL_3)PF14607(GxDLY) | 5 | LEU A 157PHE A 50LEU A 109LEU A 149ILE A 77 | None | 1.03A | 2bxqA-4lhsA:undetectable | 2bxqA-4lhsA:21.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4mbg | CAAXFARNESYLTRANSFERASEBETA SUBUNIT RAM1 (Aspergillusfumigatus) |
PF00432(Prenyltrans) | 5 | LEU B 491LEU B 124HIS B 129LEU B 411ALA B 437 | None | 0.89A | 2bxqA-4mbgB:undetectable | 2bxqA-4mbgB:20.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4mwg | PUTATIVEDIHYDROMETHANOPTERINREDUCTASE (AFPA) (Paraburkholderiaxenovorans) |
PF02441(Flavoprotein) | 5 | LEU A 39PHE A 18LEU A 35LEU A 178ILE A 129 | None | 1.00A | 2bxqA-4mwgA:undetectable | 2bxqA-4mwgA:15.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4oun | MINI-RIBONUCLEASE 3 (Bacillussubtilis) |
PF00636(Ribonuclease_3) | 5 | LEU A 129PHE A 46LEU A 85ILE A 81ALA A 146 | None | 0.99A | 2bxqA-4ounA:undetectable | 2bxqA-4ounA:14.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4pfw | ABC TRANSPORTERSUBSTRATE-BINDINGPROTEIN (Thermotogamaritima) |
PF00496(SBP_bac_5) | 6 | LEU A 282LEU A 401ILE A 397SER A 301ILE A 302ALA A 299 | None | 1.38A | 2bxqA-4pfwA:undetectable | 2bxqA-4pfwA:19.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4pj6 | LEUCYL-CYSTINYLAMINOPEPTIDASE (Homo sapiens) |
PF01433(Peptidase_M1)PF11838(ERAP1_C) | 5 | LEU A1025PHE A 750LEU A 787LEU A 779ILE A 775 | None | 1.02A | 2bxqA-4pj6A:3.0 | 2bxqA-4pj6A:21.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) |
PF00273(Serum_albumin) | 7 | LEU A 219ARG A 222PHE A 223LEU A 238HIS A 242LEU A 260ILE A 290 | None | 0.76A | 2bxqA-4po0A:40.4 | 2bxqA-4po0A:74.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4po0 | SERUM ALBUMIN (Oryctolaguscuniculus) |
PF00273(Serum_albumin) | 5 | LEU A 219LEU A 238HIS A 242ARG A 257LEU A 260 | None | 0.77A | 2bxqA-4po0A:40.4 | 2bxqA-4po0A:74.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4tz0 | ATP-DEPENDENT RNAHELICASE MSS116,MITOCHONDRIAL (Saccharomycescerevisiae) |
PF00270(DEAD)PF00271(Helicase_C) | 5 | LEU A 533PHE A 352ILE A 356ILE A 451ALA A 380 | None | 0.98A | 2bxqA-4tz0A:2.1 | 2bxqA-4tz0A:22.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4wxb | SERINEHYDROXYMETHYLTRANSFERASE (Streptococcusthermophilus) |
PF00464(SHMT) | 5 | LEU A 331LEU A 338ILE A 24ILE A 376ALA A 377 | None | 1.00A | 2bxqA-4wxbA:undetectable | 2bxqA-4wxbA:20.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4z64 | PHYTOSULFOKINERECEPTOR 1 (Arabidopsisthaliana) |
PF00560(LRR_1)PF08263(LRRNT_2)PF13855(LRR_8) | 5 | LEU A 154LEU A 129LEU A 149ILE A 167ILE A 144 | NoneNoneNoneNoneNAG A 702 (-4.8A) | 0.79A | 2bxqA-4z64A:undetectable | 2bxqA-4z64A:19.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5avo | HOMOSERINEDEHYDROGENASE (Sulfurisphaeratokodaii) |
PF00742(Homoserine_dh)PF03447(NAD_binding_3) | 6 | LEU A 27LEU A 19LEU A 3ILE A 68ILE A 98ALA A 292 | None | 1.36A | 2bxqA-5avoA:undetectable | 2bxqA-5avoA:19.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5c7m | E3 UBIQUITIN-PROTEINLIGASE ITCHY HOMOLOG (Homo sapiens) |
PF00632(HECT) | 6 | LEU A 886PHE A 815LEU A 877LEU A 875ILE A 894ALA A 893 | None | 1.45A | 2bxqA-5c7mA:undetectable | 2bxqA-5c7mA:22.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5c9e | SEPL (Escherichiacoli) |
PF07201(HrpJ) | 6 | LEU A 167LEU A 154LEU A 137SER A 135ILE A 100ALA A 131 | None | 1.31A | 2bxqA-5c9eA:2.9 | 2bxqA-5c9eA:20.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5cee | NAD-DEPENDENT MALICENZYME (Aster yellowswitches'-broomphytoplasma) |
PF00390(malic)PF03949(Malic_M) | 6 | LEU A 204LEU A 234LEU A 213ILE A 189ILE A 199ALA A 198 | None | 1.33A | 2bxqA-5ceeA:undetectable | 2bxqA-5ceeA:22.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5cqb | DITRANS,POLYCIS-UNDECAPRENYL-DIPHOSPHATESYNTHASE((2E,6E)-FARNESYL-DIPHOSPHATE SPECIFIC) (Escherichiacoli) |
PF01255(Prenyltransf) | 6 | PHE A 224LEU A 233HIS A 16LEU A 191ILE A 193ILE A 23 | None | 1.39A | 2bxqA-5cqbA:undetectable | 2bxqA-5cqbA:16.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5cyk | RIBOSOME BIOGENESISPROTEIN YTM1 (Chaetomiumthermophilum) |
PF00400(WD40)PF08154(NLE) | 6 | LEU A 147PHE A 185LEU A 155HIS A 176LEU A 215ALA A 192 | None | 1.44A | 2bxqA-5cykA:undetectable | 2bxqA-5cykA:21.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5dqf | SERUM ALBUMIN (Equus caballus) |
PF00273(Serum_albumin) | 10 | LEU A 218PHE A 222LEU A 237HIS A 241ARG A 256LEU A 259ILE A 263SER A 286ILE A 289ALA A 290 | NoneNonePG4 A 602 (-4.7A)PG4 A 602 (-4.0A)PG4 A 602 (-4.1A)PG4 A 602 ( 4.5A)NonePG4 A 602 (-3.9A)PG4 A 602 ( 4.4A)PG4 A 602 (-3.4A) | 0.62A | 2bxqA-5dqfA:41.5 | 2bxqA-5dqfA:76.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5dqf | SERUM ALBUMIN (Equus caballus) |
PF00273(Serum_albumin) | 6 | LYS A 198HIS A 241ILE A 263SER A 286ILE A 289ALA A 290 | PG4 A 602 ( 4.3A)PG4 A 602 (-4.0A)NonePG4 A 602 (-3.9A)PG4 A 602 ( 4.4A)PG4 A 602 (-3.4A) | 1.21A | 2bxqA-5dqfA:41.5 | 2bxqA-5dqfA:76.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ed1 | DOUBLE-STRANDEDRNA-SPECIFIC EDITASE1 (Homo sapiens) |
PF02137(A_deamin) | 5 | LEU A 556ILE A 545SER A 517ILE A 520ALA A 521 | None | 0.96A | 2bxqA-5ed1A:undetectable | 2bxqA-5ed1A:20.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5fa1 | PUTATIVE N-ACETYLGLUCOSAMINYLTRANSFERASE (Raoultellaterrigena) |
PF05159(Capsule_synth) | 6 | LEU A 341LEU A 204LEU A 201ILE A 307ILE A 324ALA A 336 | None | 1.42A | 2bxqA-5fa1A:undetectable | 2bxqA-5fa1A:21.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5fei | DISTAL TUBE PROTEIN (Bacillus virusphi29) |
PF16838(Caud_tail_N) | 5 | LEU A 174LEU A 239ILE A 252ILE A 408ALA A 407 | None | 0.94A | 2bxqA-5feiA:undetectable | 2bxqA-5feiA:21.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5fjj | BETA-GLUCOSIDASE (Aspergillusoryzae) |
PF00933(Glyco_hydro_3)PF01915(Glyco_hydro_3_C)PF14310(Fn3-like) | 5 | LEU A 410LEU A 501ILE A 548ILE A 583ALA A 584 | None | 1.03A | 2bxqA-5fjjA:undetectable | 2bxqA-5fjjA:21.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ghk | SERUM ALBUMIN (Canis lupus) |
PF00273(Serum_albumin) | 9 | LEU A 219ARG A 222PHE A 223LEU A 238HIS A 242ARG A 257LEU A 260SER A 287ALA A 291 | None | 0.66A | 2bxqA-5ghkA:38.2 | 2bxqA-5ghkA:79.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ghk | SERUM ALBUMIN (Canis lupus) |
PF00273(Serum_albumin) | 8 | LYS A 195LEU A 219PHE A 223LEU A 238ARG A 257LEU A 260SER A 287ALA A 291 | None | 1.01A | 2bxqA-5ghkA:38.2 | 2bxqA-5ghkA:79.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ghk | SERUM ALBUMIN (Canis lupus) |
PF00273(Serum_albumin) | 8 | LYS A 199ARG A 222PHE A 223HIS A 242ARG A 257LEU A 260SER A 287ALA A 291 | None | 1.03A | 2bxqA-5ghkA:38.2 | 2bxqA-5ghkA:79.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hdh | TOLL-LIKE RECEPTOR 8 (Homo sapiens) |
PF13855(LRR_8) | 5 | LEU A 413PHE A 417LEU A 382LEU A 401ILE A 399 | None | 1.00A | 2bxqA-5hdhA:undetectable | 2bxqA-5hdhA:21.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5mlc | 50S RIBOSOMALPROTEIN L23,CHLOROPLASTIC (Spinaciaoleracea) |
PF00276(Ribosomal_L23) | 5 | LEU V 187LEU V 178ILE V 176SER V 152ILE V 151 | None | 1.03A | 2bxqA-5mlcV:undetectable | 2bxqA-5mlcV:14.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5n8n | EVPB FAMILY TYPE VISECRETION PROTEIN (Pseudomonasaeruginosa) |
no annotation | 5 | LYS B 123LEU B 242PHE B 350LEU B 179LEU B 231 | None | 0.98A | 2bxqA-5n8nB:undetectable | 2bxqA-5n8nB:10.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ojs | TRANSCRIPTION-ASSOCIATED PROTEIN 1 (Saccharomycescerevisiae) |
PF00454(PI3_PI4_kinase)PF02259(FAT) | 5 | LEU T3171LEU T3141ILE T3137ILE T3159ALA T3160 | None | 1.00A | 2bxqA-5ojsT:undetectable | 2bxqA-5ojsT:9.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ori | ALBUMIN (Capra hircus) |
no annotation | 9 | LEU A 218LEU A 237HIS A 241ARG A 256LEU A 259ILE A 263SER A 286ILE A 289ALA A 290 | None | 0.75A | 2bxqA-5oriA:40.2 | 2bxqA-5oriA:74.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ori | ALBUMIN (Capra hircus) |
no annotation | 9 | LEU A 218PHE A 222LEU A 237HIS A 241LEU A 259ILE A 263SER A 286ILE A 289ALA A 290 | None | 0.67A | 2bxqA-5oriA:40.2 | 2bxqA-5oriA:74.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vil | MITOGEN-ACTIVATEDPROTEIN KINASEKINASE KINASE 5 (Homo sapiens) |
no annotation | 6 | LEU A 938PHE A 937LEU A 788LEU A 867ILE A 871ILE A 915 | None | 1.32A | 2bxqA-5vilA:undetectable | 2bxqA-5vilA:8.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5w6l | RTXREPEAT-CONTAININGCYTOTOXIN (Vibriovulnificus) |
no annotation | 5 | LEU A3598LEU A3620HIS A3624LEU A3638ILE A3642 | LEU A3598 ( 0.6A)LEU A3620 ( 0.6A)HIS A3624 ( 1.0A)LEU A3638 ( 0.6A)ILE A3642 ( 0.7A) | 1.01A | 2bxqA-5w6lA:3.4 | 2bxqA-5w6lA:9.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wvg | CHITINASE (Ostriniafurnacalis) |
no annotation | 6 | LEU A 661PHE A 613LEU A 665LEU A 642ILE A 603ALA A 685 | None | 1.41A | 2bxqA-5wvgA:undetectable | 2bxqA-5wvgA:9.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xsq | NUCLEOPROTEIN (Marburgmarburgvirus) |
PF05505(Ebola_NP) | 5 | LEU A 43PHE A 116LEU A 36ILE A 169ALA A 25 | None | 1.01A | 2bxqA-5xsqA:2.6 | 2bxqA-5xsqA:20.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5yxe | SERUM ALBUMIN (Felis catus) |
no annotation | 9 | LEU A 219PHE A 223LEU A 238HIS A 242ARG A 257LEU A 260ILE A 264SER A 287ILE A 290 | None | 0.65A | 2bxqA-5yxeA:37.8 | 2bxqA-5yxeA:11.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5yxe | SERUM ALBUMIN (Felis catus) |
no annotation | 9 | LYS A 199LEU A 219PHE A 223HIS A 242ARG A 257LEU A 260ILE A 264SER A 287ILE A 290 | None | 0.92A | 2bxqA-5yxeA:37.8 | 2bxqA-5yxeA:11.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5zvs | PUTATIVE COREPROTEIN NTPASE/VP5 (Aquareovirus C) |
no annotation | 5 | LEU 4 27PHE 4 37LEU 4 209ILE 4 4ALA 4 243 | None | 0.95A | 2bxqA-5zvs4:undetectable | 2bxqA-5zvs4:8.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6eti | ATP-BINDING CASSETTESUB-FAMILY G MEMBER2 (Homo sapiens) |
no annotation | 5 | LEU A 75PHE A 253LEU A 228ILE A 249ILE A 242 | None | 0.95A | 2bxqA-6etiA:undetectable | 2bxqA-6etiA:8.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6ez8 | HUNTINGTIN (Homo sapiens) |
no annotation | 5 | LEU A1614LEU A1630LEU A1581ILE A1575ILE A1606 | None | 1.04A | 2bxqA-6ez8A:undetectable | 2bxqA-6ez8A:6.81 |